BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 22490869)

  • 1. NLRC5 cooperates with the RFX transcription factor complex to induce MHC class I gene expression.
    Meissner TB; Liu YJ; Lee KH; Li A; Biswas A; van Eggermond MC; van den Elsen PJ; Kobayashi KS
    J Immunol; 2012 May; 188(10):4951-8. PubMed ID: 22490869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC5 exclusively transactivates MHC class I and related genes through a distinctive SXY module.
    Ludigs K; Seguín-Estévez Q; Lemeille S; Ferrero I; Rota G; Chelbi S; Mattmann C; MacDonald HR; Reith W; Guarda G
    PLoS Genet; 2015 Mar; 11(3):e1005088. PubMed ID: 25811463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NLRC5 controls basal MHC class I gene expression in an MHC enhanceosome-dependent manner.
    Neerincx A; Rodriguez GM; Steimle V; Kufer TA
    J Immunol; 2012 May; 188(10):4940-50. PubMed ID: 22490867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A functionally essential domain of RFX5 mediates activation of major histocompatibility complex class II promoters by promoting cooperative binding between RFX and NF-Y.
    Villard J; Peretti M; Masternak K; Barras E; Caretti G; Mantovani R; Reith W
    Mol Cell Biol; 2000 May; 20(10):3364-76. PubMed ID: 10779326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal NLRC5 regulates MHC class I expression in Neuro-2a cells and also during hippocampal development.
    Li P; Shen Y; Cui P; Hu Y; Zhang Y; Miao F; Zhang A; Zhang J
    J Neurochem; 2020 Jan; 152(2):182-194. PubMed ID: 31549732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A gene encoding a novel RFX-associated transactivator is mutated in the majority of MHC class II deficiency patients.
    Masternak K; Barras E; Zufferey M; Conrad B; Corthals G; Aebersold R; Sanchez JC; Hochstrasser DF; Mach B; Reith W
    Nat Genet; 1998 Nov; 20(3):273-7. PubMed ID: 9806546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel mutations in the RFXANK gene: RFX complex containing in-vitro-generated RFXANK mutant binds the promoter without transactivating MHC II.
    Wiszniewski W; Fondaneche MC; Louise-Plence P; Prochnicka-Chalufour A; Selz F; Picard C; Le Deist F; Eliaou JF; Fischer A; Lisowska-Grospierre B
    Immunogenetics; 2003 Feb; 54(11):747-55. PubMed ID: 12618906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nucleotide-binding domain of NLRC5 is critical for nuclear import and transactivation activity.
    Meissner TB; Li A; Liu YJ; Gagnon E; Kobayashi KS
    Biochem Biophys Res Commun; 2012 Feb; 418(4):786-91. PubMed ID: 22310711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLR family member NLRC5 is a transcriptional regulator of MHC class I genes.
    Meissner TB; Li A; Biswas A; Lee KH; Liu YJ; Bayir E; Iliopoulos D; van den Elsen PJ; Kobayashi KS
    Proc Natl Acad Sci U S A; 2010 Aug; 107(31):13794-9. PubMed ID: 20639463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New functions of the major histocompatibility complex class II-specific transcription factor RFXANK revealed by a high-resolution mutagenesis study.
    Krawczyk M; Masternak K; Zufferey M; Barras E; Reith W
    Mol Cell Biol; 2005 Oct; 25(19):8607-18. PubMed ID: 16166641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MHC-specific enhanceosome and its role in MHC class I and beta(2)-microglobulin gene transactivation.
    Gobin SJ; van Zutphen M; Westerheide SD; Boss JM; van den Elsen PJ
    J Immunol; 2001 Nov; 167(9):5175-84. PubMed ID: 11673530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long distance control of MHC class II expression by multiple distal enhancers regulated by regulatory factor X complex and CIITA.
    Krawczyk M; Peyraud N; Rybtsova N; Masternak K; Bucher P; Barras E; Reith W
    J Immunol; 2004 Nov; 173(10):6200-10. PubMed ID: 15528357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The transcription factor RFX protects MHC class II genes against epigenetic silencing by DNA methylation.
    Seguín-Estévez Q; De Palma R; Krawczyk M; Leimgruber E; Villard J; Picard C; Tagliamacco A; Abbate G; Gorski J; Nocera A; Reith W
    J Immunol; 2009 Aug; 183(4):2545-53. PubMed ID: 19620312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major histocompatibility complex class II transcriptional platform: assembly of nuclear factor Y and regulatory factor X (RFX) on DNA requires RFX5 dimers.
    Jabrane-Ferrat N; Nekrep N; Tosi G; Esserman LJ; Peterlin BM
    Mol Cell Biol; 2002 Aug; 22(15):5616-25. PubMed ID: 12101253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The balance between nuclear import and export of NLRC5 regulates MHC class I transactivation.
    Zhu B; Ouda R; An N; Tanaka T; Kobayashi KS
    J Biol Chem; 2024 May; 300(5):107205. PubMed ID: 38519032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purified X2 binding protein (X2BP) cooperatively binds the class II MHC X box region in the presence of purified RFX, the X box factor deficient in the bare lymphocyte syndrome.
    Moreno CS; Emery P; West JE; Durand B; Reith W; Mach B; Boss JM
    J Immunol; 1995 Nov; 155(9):4313-21. PubMed ID: 7594590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins.
    Burd AL; Ingraham RH; Goldrick SE; Kroe RR; Crute JJ; Grygon CA
    Biochemistry; 2004 Oct; 43(40):12750-60. PubMed ID: 15461447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain of NLRC5 confers transcriptional activity for MHC class I and II gene expression.
    Neerincx A; Jakobshagen K; Utermöhlen O; Büning H; Steimle V; Kufer TA
    J Immunol; 2014 Sep; 193(6):3090-100. PubMed ID: 25127861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The X1 box of HLA-G promoter is a target site for RFX and Sp1 factors.
    Rousseau P; Paul P; O'Brien M; Dausset J; Carosella ED; Moreau P
    Hum Immunol; 2000 Nov; 61(11):1132-7. PubMed ID: 11137218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.